Insulin-like growth factor and the etiology of autism

Medical Hypotheses

Volumn 80, Issue 4, 2013, Pages 475-480

  Steinman, Gary ^a   Mankuta, David ^b  

^a Touro University College of Pharmacy and School of Osteopathic Medicine   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ARTICLE; AUTISM; DISEASE MARKER; ENVIRONMENTAL FACTOR; EPIGENETICS; HEREDITY; HUMAN; MYELINATION; NERVOUS SYSTEM DEVELOPMENT; OLIGODENDROGLIA; PROSPECTIVE STUDY; PUERPERIUM; UMBILICAL CORD BLOOD;

AUTISTIC DISORDER; BIOLOGICAL MARKERS; COMPUTER SIMULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MODELS, BIOLOGICAL;

EID: 84875391325     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.01.010     Document Type: Article

References (106)

1. Kogan M.D., Blumberg S.J., Schieve L.A., et al. Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US. Ped 2009 2007, 124(5):1395-1403.
2. Ozonoff S., Young G.S., Carter A., et al. Recurrence risk for autism spectrum disorders: a baby siblings research consortium study. Peds 2011, 128:e488-95.
3. Hallmayer J, Cleveland S, Torres A, et al. General heritability and shared environmental factors among twin pairs with autism. doi:10.1001/archgenpsychiatry.2011.76.
4. Miles J.H. Autism spectrum disorders-a genetics review. Genet Med 2011, 13(4):278-294.
5. Geschwind D.H. Genetics of autism spectrum disorder. Trends Cognit Sci 2011, 15(9):409-416.
6. Onuma T.A., Ding Y., Abraham E., Zohar Y., Ando H., Duan C. Regulation of temporal and spatial organization of newborn GnRH neurons by IGF signaling in zebrafish. J Neurosci 2011, 31(33):11814-11824.
7. Beck K.D., Powell-Braxton L., Widmer H.R., Valverde J., Hefti F. IGF1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 1995, 14:717-730.
8. Woods K.A., Camacho-Hübner C., Savage M.O., Clark A.J. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. NEJM 1996, 335:1363-1367.
9. Rietveld I. A polymorphism in the IGF-1 gene influences the age-related decline in circulating total IGF-1 levels. Europ J Endocrin 2003, 148:171-175.
10. Baumert M., Grabowska Z., Wojciechowska E., et al. Insulin-like growth factor-1 (IGF-1) serum concentration in umbilical blood of term and preterm neonates. Med Sci Monit 2004, 10(suppl 2):80-82.
11. Arends N., Johnston L., Hokken-Koelega A., et al. Polymorphism in the IGF-I gene: Clinical relevance for short children born small for gestational age (SGA). J Clin Endocrin Metab 2002, 87(6):2720-2724.
12. Grandis M., Nobbio L., Abbruzzese M., et al. Insulin treatment enhances expression of IGF-1 in sural nerves of diabetic patients. Muscle Nerve 2001, 24(5):622-629.
13. Verhaeghe J., Coopmans W., van Herck E., van Schoubroeck D., Deprest J.A., Witters I. IGF-I, IGF-II, IGF binding protein 1, and C-peptide in second trimester amniotic fluid are dependent on gestation age but no not predict weight at birth. Ped Res 1999, 46(1):101-108.
14. Chellakooty M., Skibsted L., Skouby S.O., et al. Longitudinal study of serum placental GH in 455 normal pregnancies: correlation to gestational age, fetal gender, and weight. J Clin Endocrinol Metab. 2002, 87(6):2734-2739.
15. Leavey, A, Swaigenbaum, L, Heavner, K, Burstyn, I. Gestational age at birth and risk of autism spectrum disorder in Alberta Canada. J Ped. doi:10.1016/j.peds.2012.07.040.
16. Ohkawa N., Shoji H., Kitamura T., et al. IGF-1, leptin and active ghrelin levels in very low birth weight infants during the first 8 weeks of life. Acta Paediatr 2010, 99:37-41.
17. Bajoria R., Sooranna S.R., Ward S., Hancock M. Placenta as a link between amino acids, insulin-IGF axis, and low birth weight: evidence from twin studies. J Clin Endocrinol Meta 2002, 87:308-315.
18. Sorem K.A., Siler-Khodr T.M. Placental IGF-1 in severe intrauterine growth retardation. J Maternal-Fetal Med 1998, 7:1-7.
19. Iwashita M., Kobayashi M., Matsuo A., et al. Feto-maternal interactions of IGF-I and its binding proteins in fetal growth. Early Hum Dev 1992, 29:187-191.
20. Pinto-Martin J.A., Levy S.E., Feldman J.F., et al. Prevalence of autism spectrum disorder in adolescents born weighing <2000grams. Pediatrics 2011, 128(4):2010-2846.
21. Zhao P., Zhang X.L., Yu C., Lu X.Y., Wang Y.M. Umbilical cord serum levels of insulin-like growth factor, insulin, and growth hormone in neonates with IUGR. Zhonggoo Dang Dai Er Ke Za Zhi 2010, 12(10):771-773.
22. Boyne M.S., Thame M., Bennett F.I., Osmond C., Miell J.P., Forrester T.E. The relationship among circulating insulin-like growth factor (IGF)-1, IGF-binding proteins-1 and -2, and birth anthropometry: a prospective study. J Clin Endoc Metab 2003, 88(4):1687-1691.
23. Blanco C.L., Ferry R.J. The insulin-like growth factor axis in the fetus and neonate. IGF and nutrition in health and disease 2005, 133-143. Humana Press, Totowa, NJ. M.S. Houston, N.M.P. Holly, E.L. Feldman (Eds.).
24. Hsiao E.Y., Patterson P.H. Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain behav immun 2010, 10.1016/j.bbi.12.017.
25. Patterson P.H. Maternal infection and immune involvement in autism. Trends Molec Med 2011, 17(7):389-394.
26. Elovitz M.A., Bdrown A.G., Breen K., et al. Intrauterine inflammation, insufficient to induce parturition, still evokes fetal and neonatal brain injury. Int J Dev Neurosci 2011, 29(6):663-671.
27. Butt A.M., Berry M. Oligodendrocytes and the control of myelination in vivo: new insights from the rat anterior medullary velum. J Neurosci Res 2000, 59(4):477-488.
28. Malkova N.V., Yu C.Z., Hsiao E.Y., Moore M.J., Patterson P.H. Comparison of umbilical cord interleukin-6 in preterm infants with premature rupture of membranes and intact membranes. Saudi Med J 2008, 29(2):224-228.
29. Wei H., Zou H., Sheikh A.M., et al. IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation. J Neuroinflam 2001, 10.1186/1742-2094.8.52.
30. Durkin M.S., Maenner M.J., Newschaffer C.J., et al. Advanced parental age and the risk of autism spectrum disorder. Am J Epidemiol 2008, 168(11):1268-1276.
31. Gardener H., Spiegelman D., Buka S.L. Prenatal risk factors for autism: comprehensive meta-analysis. Br J Psychiatry 2009, 195(1):7-14.
32. Kong A., Frigge M.L., Massen G., et al. Rate of de novo mutations and importance of father's age to disease risk. Nature 2012, 488:471-475.
33. Skalkidou A., Petridou E., Papathoma E., et al. Determinants and consequences of major insulin-like growth factor components among full-term healthy neonates. Cancer Epidemiol Biomarkers Prev 2003, 12(9):860-865.
34. Maccario M., Ramunni J., Oleandri S.E., et al. Relationship between IGF-1 & age, gender, body mass, fat distribution, metabolic & hormonal variables in obese patients. Intl J Obesity 1999, 23(6):612-618.
35. Dinleyici E.C., Tekin N., Colak O. Aksit MA Cord blood IGF-1 and IGFBP-3 levels in asphyxiated term newborns. Neuro Endocrinol Lett. 2006, 27(6):745-747.
36. Kolvezon A., Gross R., Reichenberg A. Prenatal and perinatal risk factors for autism. Arch Pediatr Adoles Med 2007, 161(4):326-333.
37. Gluckman P.D., Guan J., Williams C., Scheepens A., Zhang R., Bennet L., et al. Asphyxial brain injury-the role of IGF system. Mol Cell Endocrinol 1998, 140:95-99.
38. Guan J., Bennet T.L., George S., et al. Selective neuroprotective effects with insulin-like growth factor-1 in phenotypic striatal neurons following ischemic brain injury in fetal sheep. Neuroscience 2000, 95:831-839.
39. Hoppe C. High intakes of skimmed milk, but not meat, increase serum IGF-I and IGFBP-3 in eight-year-old boys. Euro J Clin Nutr 2004, 58(9):1211-1216.
40. Steinman G. Can the chance of having twins be modified by diet?. The Lancet 2006, 367:1461-1462.
41. Díaz-Gómez N.M., Domenech E. Barroso F Breast-feeding and growth factors in preterm newborn infants. J Ped Gastro & Nutrition 1997, 24(3):322-327.
42. Schultz S.T., Klonoff-Cohen H.S., Wingard D.L., et al. Breastfeeding, infant formula supplementation, and autistic disorder: the results of parent survey. Inter Breastfeeding J 2006, I:16. 10.1186/1746-4358-1-16.
43. Tanoue Y., Oda S. Weaning time of children with infantile autism. J Autism Dev Disorders 1989, 19(3):425-434.
44. Shen W.H., Xu R.J. Stability of insulin-like factor I in the gastrointestinal lumen in neonatal pigs. J Pediatr Gastrointest Nutr 2000, 30:299-304.
45. Herndon A.C., DiGuiseppi C., Johnson S.L., Leiferman J., Reynolds A. Does nutrition intake differ between children with autism spectrum disorders and children with typical development?. J Autism Dev Disord 2009, 39:212-222.
46. Zachor, DA, Ben Itzchak, E. Assisted reproductive technology and risk for autism spectrum disorder. Res in Develop Disab 2011. doi:10.1016/j.rid.2011.05.007.
47. Kai C.M., Main K.M., Andersen A.N., et al. Serum insulin-like growth factor-I (IGF-I) and growth in children born after assisted reproduction. J Clin endocrinol Metab 2006, 91(11):4352-4360.
48. Morell P., Quarles R.H. Myelin formation, structure and biochemistry. Basic Neurochemistry 1999, 70-93. Lippincott Williams & Wilkins, Baltimore. G.J. Siegel, B.W. Agranoff, R.W. Albers, S.K. Fisher, M.D. Uhler (Eds.).
49. Ye P., Li L., Richards R.G., DiAugustine R.P., D'Ercole A.J. Myelination is altered in insulin-like growth factor-1 null mutant mice. J Neurosci 2002, 22(14):6041-6051.
50. Bondy C.A. Transient IGF-1 gene expression during maturation of functionally related central projection neurons. J Neurosci 1991, 11(11):3442-3455.
51. Hsieh J., Aimone J.B., Kaspar B.K., Kuwabara T., Nakashima K., Gage F.H. IGF-1 instructs multipotent adult neural progenitor cells to become oligodendrocytes. J Cell Biology 2004, 164:111-122.
52. Zikopoulos B., Barbas H. Changes in prefrontal axons may disrupt the network in autism. J Neurosci 2010, 30(44):14595-14608.
53. Deoni S.C.L., Mercure E., Blasi A., et al. Mapping infant brain myelination with magnetic resonance imaging. J Neurosci 2011, 31(2):784-791.
54. Carson M.J., Behringer R.R., Brinster R.L., McMorris G.A. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 1993, 10:729-740.
55. Nishijima T., Piriz J., Duflot S., et al. Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-1 into the CNS. Neuron 2010, 67:834-846.
56. Riikonen R. Insulin-like growth factor delivery across the blood-brain barrier. Chemotherapy 2006, 52:279-281.
57. Lin X., Bulleit R.F. Insulin-like growth factor I (IGF-I) is a critical trophic factor for developing cerebellar granule cells. Brain Res Dev Brain Res 1997, 99(2):234-242.
58. Vanhala R., Turpeinen U., Riikonen R. Low levels of insulin-like growth factor-1 in cerebrospinal fluid in children with autism. Devel Med & Child Neuro 2001, 43:614-616.
59. Riikonen R. Insulin-like growth factors-neurobiological regulators of brain growth in autism?. Autism-current theories and evidence 2008, 233-244. Humana Press, Totowa, NJ. A.W. Zimmerman (Ed.).
60. Riikonen R. Cerebrospinal fluid insulin-like growth factors IGF-1 and IGF-2 in infantile autism. Devel Med & Child Neuro 2006, 48(9):751-755.
61. Bauman M.L., Kemper T.L. Neuroanatomic observations of the brain in autism. The neurobiology of autism 1994, 119-145. Johns Hopkins Press, Baltimore. M.L. Bauman, T.L. Kemper (Eds.).
62. Akshoomoff N., Pierce K., Courchesne E. The neurobiological basis of autism from a developmental perspective. Devel Psycholpath 2002, 14:613-634.
63. Porterfield SP. Endocrine physiology. 2nd ed. St.Louis: Mosby; 1796.p. 33-38.
64. Niblock M.M., Brunso-Bechtold J.K., Riddle D.R. Insulin-like growth factor I stimulates dendritic growth in primary somatosensory cortex. J Neurosci 2000, 20(11):4165-4176.
65. Gunnell D., Miller L.L., Rogers I., Holly J.M. Association of insulin-like growth factor I and insulin-like growth factor-binding protein-3 with intelligence quotient among 8-9-year-old children-The Avon longitudinal study of parents and children. Pediatrics 2005, 116(5):e681-6.
66. van Pareren Y.K., Duivenvoorden H.J., Slijper F.S., Koot H.M., Hokken-Koelega A.C. Intelligence and psychosocial functioning during long-term growth hormone therapy in children born small for gestational age. J Clin Endocrinol Metab 2004, 89:5295-5302.
67. Steinman G.D., Verni C. Womb Mates-a modern guide to fertility and twinning 2007, Baffin Books, New York, pp. 53-8.
68. Steinman G. Are mothers of twins more intelligent? poster. Touro College; 2012.
69. Curran S., Dworzynski K., Happé F., et al. No major effect of twinning on autistic traits. Autism Res 2011, 4:377-382.
70. Santucci D. Anti-insulin-like growth factor I antibodies affect locomotion and passive avoidance performances. Sprague-Dawley rats in IGFs in the nervous system 1998, 135-144. Springer, Milano. E.E. Muller (Ed.).
71. Sara V.R., Carlsson-Skwirut C. The role of insulin-like factors in the regulation of brain development. Prog Brain Res 1988, 73:87-99.
72. Bangash M.A., Park J.M., Melnikova T., et al. Enhanced polyubiquitination of shank3 and NMDA receptor in a mouse model of autism. Cell 2011, 145:758-772.
73. Baker A.M., Batchelor D.C., Thomas G.B., et al. Central penetration and stability of N-terminal tripeptide of insulin-like growth factor-I, glycine-proline-glutamate in adult rat. Neuropeptide 2005, 39(2):81-87.
74. Tropea D., Giacometti E., Wilson N.R., et al. Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. PNAS 2009, 106(6):2029-2034.
75. Riikonen R. Neurotrophic factors in the pathogenesis of Rett syndrome. J Child Neurol 2003, 18:693-697.
76. Bolton P.F., Roobol M., Allsopp L., Pickles A. Association between idiopathic infantile macrocephaly and autism spectrum disorders. Lancet 2001, 358:726-727.
77. Lainhart J.E., Piven J., Wzorek M., et al. Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry 1997, 36:282-290.
78. Huntman C.M., Sparen P., Cnattingius S. Perinatal risk factors for infantile autism. Epidemiology 2002, 13(4):417-423.
79. Williams C.A., Dagli A., Battaglia A. Genetic disorders associated with macrocephaly. Am J Med Genet A 2008, 146A(15):2023-2037.
80. Courchesne E., Carper R., Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA 2003, 290:337-344.
81. Mraz K.D., Green J., Dumont-Mathieu T., Makin S., Fein D. Correlates of head circumference growth in infants later diagnosed with autism spectrum disorders. J Child Neurol 2007, 22:700-713.
82. Torrey E.F., Dhavale D., Lawlor J.P., Yolken R.H. Autism and head circumference in the first year of life. Biol Psychiatry 2004, 56(11):892-894.
83. Fombonne E., Roge B., Claverie J., Courty S., Fremolle J. Microcephaly and macrocephaly in autism. J Autism Dev Disorder 1999, 29:113-119.
84. Bauman M.L., Filipek P.A., Kemper T.L. Early infantile autism. Int Rev Neurobiol 1997, 41:367-386.
85. Webb S.J., Nalty T., Munson J., et al. Rate of head circumference growth as a function of autism diagnosis and history of autistic regression. J Child Neurol 2007, 22:1182-1190.
86. Hazlett H.C., Poe M., Gerig G., et al. Magnestic resonance imaging and head circumference study of brain size in autism: birth through age twoyears. Arch Gen Psychiatry 2005, 62:1366-1376.
87. Mills J.L., Hediger M.L., Molloy C.A., et al. Elevated levels of growth-related hormones in autism and autism spectrum disorder. Clin Endocrinol (Oxf) 2007, 67(2):230-237.
88. Anlar B., Oktem F., Bakkaloglu B., et al. Urinary epidermal and insulin-like growth factor excretion in autistic children. Neuropediatrics 2007, 38:151-153.
89. Nagano I., Shiote M., Murakami T., et al. Beneficial effects of Intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis. Neurol Res 2005, 27(7):768-772.
90. Chesik D., Wilczak N., DeKeyser J. The insulin-like growth factor system in multiple sclerosis. Int Rev Neurobiol 2007, 79:203-226.
91. Leventhal P.S., Russell J.W., Feldman E.L. IGFs and the nervous system. The IGF System-molecular biology, physiology, and clinical applications 1999, 425-455. Humana Press, Totowa, NJ. R.G. Rosenfeld, C.T. Roberts (Eds.).
92. Lai E.D., Felice K.J., Festoff B.W., et al. Effect of recombinant human insulin-like factor-I on progression of ALS: a placebo-controlled study. Neuro 1997, 49:1621-1630.
93. Borasio G.D., Robberecht W., Leigh P.N., et al. A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. Neurology 1998, 51(2):583-586.
94. Carro E., Trejo J.L., Núñez A., Torres-Aleman I. Brain repair and neuroprotection by serum insulin-like growth factor I. Mol Neurobiol 2003, 27:153-162.
95. Coutant R., Boux de Casson F., Douay O., et al. Relationships between placental GH concentrations and maternal smoking, newborn gender and maternal leptin: possible implications for birth weight. J Clin Endo Metab 2001, 86(10):4854-4859.
96. Hultman C.M., Sparen P., Cnattingius S. Perinatal risk factors for infantile autism. Epidemiology 2002, 13(4):417-423.
97. Verhaeghe J. C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. Am J Obstet Gynecol 1993, 169(1):89-97.
98. Diamandi A., Khosravi M.J., Mistry J., Martines V., Guevara-Aguirre J. Filter paper blood spot assay of human insulin-life growth factor I (IGF-I) and IFG-binding protein-3 and preliminary application in the evaluation of growth hormone status. J Clin Endo Metab 1998, 83(7):2296-2301.
99. Iguchi T., Watanabe H., Ohta Y., Blumberg B. Developmental effects: oestrogen-induced changes and organotin-induced adipogenesis. Intl J Andrology 2008, 31:263-268.
100. Makkonen I., Kokki H., Kuikka J., Turpeinen U., Riikonen R. Effects of fluoxetine treatment on striatal dopamine transporter binding and cerebrospinal fluid insulin-like growth factor-1 in children with autism. Neuroped 2011, 42(5):207-209.
101. Skihar V., Silva C., Chojnacki A., et al. Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate. NAS 2009, 106(42):17992-17997.
102. Schernhammer E.S., Holly J.M., Hunter D.J., Pollak M.N., Hankinson S.E. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk. Endo-related cancer 2006, 13(2):583-592.
103. Ichim T.E., Solano F., Glenn E., et al. Stem cell therapy for autism. J Translational Med 2007, 5:30-38.
104. Ohlsoon D. P53 regulates insulin-like factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: Interation between p53 and Sp1. Endocrinology 1998, 139:1101-1107.
105. Schoeters G., Den Hond E., Dhooge W., van Larebeke N., Leijs M. Endocrine disruptors and abnormalities of pubertal development. Basic Clin Pharm Tox 2008, 102:168-175.
106. Tricoli J.V., Rall L.B., Scott J., Bell G.I., Shows T.B. Localization of insulin-like growth factor genes to human chromosomes 11 & 12. Nature 1984, 310.